美国微创手术市场：市场规模、份额和趋势分析（按外科专科、手术类型、最终用途和支付方类型划分），细分市场预测（2025-2033 年）

市场规模与趋势：

预计到 2024 年，美国微创手术 (MIS) 市场规模将达到 1,658.9 亿美元，到 2033 年将达到 3,182.7 亿美元，2025 年至 2033 年的复合年增长率为 7.66%。

市场成长的主要驱动力是肥胖、心血管疾病和癌症等慢性疾病的日益普遍。这些疾病通常需要手术治疗，但能够缩短恢復时间、减少併发症的治疗方法尤其重要。此外，机器人手术、高画质影像、腹腔镜器械和导航系统等外科技术的进步，使外科医生能够更精准地完成复杂的手术，同时最大限度地减少病患创伤。患者对微创手术益处的认识不断提高，也进一步推动了对这类手术的需求。

手术机器人技术的进步彻底革新了微创手术（MIS），提高了外科医生的操作灵活性，改善了术野可视化（通常藉助3D成像），并促进了透过微小切口进行更精准的操作。这些优势降低了某些复杂手术的门槛，使得原本可能需要开放性手术的手术能够以微创的方式进行。根据美国医院协会（AHA）统计，截至2024年，达文西机器人手术系统在全球已完成约268万例手术，其中263万例发生在美国。因此，像达文西机器人这样的植入正在帮助扩大微创手术在泌尿系统、妇科和一般外科等专科领域的应用范围。

此外，医院数据也强有力地支持了这一趋势：已实施机器人辅助手术（RAS）的中心往往微创手术（MIS）率更高，这并非简单地用一种手术替代另一种，而是扩大了微创手术在病患小组中的应用范围。这表明，RAS并非用机器人手术取代腹腔镜手术，而是将微创手术的益处惠及更多原本可能需要接受开放性手术的病人。

内视镜检查在美国医疗保健领域至关重要，尤其是在胃肠道疾病的诊断和治疗方面。根据多方资讯来源，2023年美国共进行了约213万例内视镜检查。如此高的检查量反映了内视镜检查与微创诊断和治疗策略的紧密联繫。大肠镜检查仍然是癌症预防计画的重要组成部分，每年有超过1500万人接受此项检查。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国微创手术（MIS）市场：驱动因素、趋势与范围

• 市场联动展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 微创手术 (MIS) 市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL 分析
• 微创手术（MIS）市场：手术数量
• 微创手术（MIS）市场：平均手术费用

第四章美国微创手术（MIS）市场：外科专科的估计与趋势分析

• 细分仪表板
• 微创手术（MIS）市场：依外科专科分類的差异分析
• 微创手术（MIS）市场：依外科专科分類的展望
• 市场规模预测及趋势分析（2021-2033）
• 一般外科
• 胃肠外科手术
• 泌尿系统手术
• 心胸外科
• 整形外科/脊椎手术
• 神经外科
• 大肠直肠手术
• 减重手术
• 血管/血管内手术
• 整形外科/重组外科

第五章美国微创手术（MIS）市场：依方法分類的估计与趋势分析

• 细分仪表板
• 微创手术 (MIS) 市场：按方法分類的差异分析
• 微创手术（MIS）市场：按技术分類的展望
• 市场规模预测及趋势分析（2021-2033）
• 腹腔镜手术
• 胸腔镜手术/VATS
• 机器人辅助手术
• 内视镜手术
• 导管介入/介入治疗
• 其他的

第六章美国微创手术（MIS）市场：按支付方类型分類的估计与趋势分析

• 细分仪表板
• 微创手术 (MIS) 市场：按支付方类型分類的销售分析
• 微创手术 (MIS) 市场：按支付方类型分類的展望
• 市场规模预测及趋势分析（2021-2033）
• 私人医疗保险
• 联邦医疗保险
• 医疗补助
• 自费
• 其他付款方

第七章美国微创手术（MIS）市场：依最终用途分類的估计与趋势分析

• 细分仪表板
• 微创手术 (MIS) 市场：按最终用途分類的差异分析
• 微创手术 (MIS) 市场：按最终用途分類的展望
• 市场规模预测及趋势分析（2021-2033）
• 医院
• 门诊手术中心（ASC）
• 专科诊所
• 其他的

第八章 竞争情势

• 市场参与企业分类
• 主要企业简介
  • Medtronic plc
  • Intuitive Surgical
  • CMR Surgical
  • Smith & Nephew plc
  • Renishaw
  • Monteris Medical
  • PROCEPT BioRobotics
  • EndoQuest Robotics
  • Moon Surgical
  • Asensus Surgical US, Inc.
  • Olympus Corporation

Market Size & Trends:

The U.S. minimally invasive surgery (MIS) market size was valued at USD 165.89 billion in 2024 and is expected to reach USD 318.27 billion by 2033, growing at a CAGR of 7.66% from 2025 to 2033. A key factor driving market expansion is the rising prevalence of chronic conditions such as obesity, cardiovascular diseases, and cancer. These conditions often require surgery but benefit from approaches that shorten recovery times and lower complications. Additionally, ongoing innovations in surgical technology-like robotics, high-definition imaging, laparoscopic instruments, and navigation systems-enable surgeons to perform complex procedures more accurately while minimizing patient trauma. Increasing patient awareness about the advantages of minimally invasive techniques has further propelled the demand for these procedures.

Advances in surgical robotics have revolutionized minimally invasive surgery (MIS) by enhancing surgeons' dexterity, improving visualization (often with 3D imaging), and facilitating more precise movements through small incisions. These benefits lower the barrier of complexity for certain procedures, enabling operations that may have required open surgery to now be performed less invasively. According to the American Hospital Association (AHA), as of 2024, the da Vinci robotic surgical system facilitated around 2.68 million procedures globally, and 2.63 million were carried out in the U.S. As a result, implants such as the da Vinci robot have contributed to an expanded scope of MIS across specialties, including urology, gynecology, general surgery, and more.

Furthermore, evidence from hospital data shows this trend in action. Facilities that introduce robotic-assisted surgery (RAS) capabilities tend to increase their rate of MIS, not merely replacing one minimally invasive method with another but expanding overall usage of less invasive approaches across patient groups. This indicates that RAS does not replace laparoscopic methods for robotic ones; it enables more patients who previously might have undergone open surgery to access the benefits of MIS.

Endoscopic procedures are critical in U.S. healthcare, especially for gastrointestinal diagnosis and treatment. According to several sources, approximately 2.13 million endoscopies were performed in the U.S. in 2023. These high procedure volumes reflect how deeply endoscopy intertwines minimally invasive diagnostic and therapeutic strategies. Colonoscopy remains the cornerstone of cancer prevention programs, with more than 15 million individuals undergoing the procedure annually.

U.S. Minimally Invasive Surgery Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. minimally invasive surgery (MIS) market report based on surgical specialty, method, payer type, and end-use:

• Surgical Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Gastrointestinal Surgery
• Gynecological Surgery
• Urological Surgery
• Cardiothoracic Surgery
• Orthopedic & Spine Surgery
• Neurosurgery
• Colorectal Surgery
• Bariatric Surgery
• Vascular & Endoscopic Surgery
• Plastic & Reconstructive Surgery
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Laparoscopic Surgery
• Thoracoscopic Surgery/VATS
• Robotic-assisted Surgery
• Endoscopic Surgery
• Catheter-based/ Interventional Procedures
• Others
• Payer Type Outlook (Revenue, USD Million, 2021 - 2033)
• Private Health Insurance
• Medicare
• Medicaid
• Out-of-Pocket/ Self-pay
• Other Payers
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
  • Public Hospitals
  • Private Hospitals
  • Private Hospitals-for profit
  • Private Hospitals-non-profit
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Surgical Specialty
  • 1.2.2. Method
  • 1.2.3. Payer Type
  • 1.2.4. End-use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Surgical Specialty outlook
  • 2.2.2. Method outlook
  • 2.2.3. Payer Type outlook
  • 2.2.4. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising surgical volumes
    • 3.2.1.2. Technological advancements in surgical robotics & imaging
    • 3.2.1.3. Growing shift toward outpatient care
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High capital and procedure costs
    • 3.2.2.2. Complex training requirements
• 3.3. Minimally Invasive Surgery (MIS) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. Minimally Invasive Surgery (MIS) Market: Number of Procedures
• 3.5. Minimally Invasive Surgery (MIS) Market: Average Procedure Pricing

Chapter 4. U.S. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Movement Analysis
• 4.3. Minimally Invasive Surgery (MIS) Market by Surgical Specialty Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. General Surgery
  • 4.5.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Gastrointestinal Surgery
  • 4.6.1. Gastrointestinal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Urological Surgery
  • 4.7.1. Urological Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Cardiothoracic Surgery
  • 4.8.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Orthopedic & Spine Surgery
  • 4.9.1. Orthopedic & Spine Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Neurosurgery
  • 4.10.1. Neurosurgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Colorectal Surgery
  • 4.11.1. Colorectal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Bariatric Surgery
  • 4.12.1. Bariatric Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Vascular & Endovascular Surgery
  • 4.13.1. Vascular & Endovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Plastic & Reconstructive Surgery
  • 4.14.1. Plastic & Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Minimally Invasive Surgery (MIS) Market: Method Movement Analysis
• 5.3. Minimally Invasive Surgery (MIS) Market by Method Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Laparoscopic Surgery
  • 5.5.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Thoracoscopic Surgery/VATS
  • 5.6.1. Thoracoscopic Surgery/VATS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Robotic-assisted Surgery
  • 5.7.1. Robotic-assisted Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Endoscopic Surgery
  • 5.8.1. Endoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Catheter-based/Interventional Procedures
  • 5.9.1. Catheter-based/Interventional Procedures Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Minimally Invasive Surgery (MIS) Market: Payer Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Minimally Invasive Surgery (MIS) Market: Payer Type Movement Analysis
• 6.3. Minimally Invasive Surgery (MIS) Market by Payer Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Private Health Insurance
  • 6.5.1. Private Health Insurance Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Medicare
  • 6.6.1. Medicare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Medicaid
  • 6.7.1. Medicaid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Out-of-Pocket/Self-pay
  • 6.8.1. Out-of-Pocket/Self-pay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Other Payers
  • 6.9.1. Other Payers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Minimally Invasive Surgery (MIS) Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Minimally Invasive Surgery (MIS) Market: End-use Movement Analysis
• 7.3. Minimally Invasive Surgery (MIS) Market by End-use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.1.1. Public hospitals
    • 7.5.1.2. Private hospitals
      • 7.5.1.2.1. Private hospitals-for profit
      • 7.5.1.2.2. Private hospitals-non-profit
• 7.6. Ambulatory Surgical Centers (ASCs)
  • 7.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Specialty Clinics
  • 7.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Medtronic plc
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Intuitive Surgical
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. CMR Surgical
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Smith & Nephew plc
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Renishaw
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Monteris Medical
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. PROCEPT BioRobotics
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. EndoQuest Robotics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Moon Surgical
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Asensus Surgical US, Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Olympus Corporation
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives

List of tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. Minimally Invasive Surgery (MIS) market, by surgical specialty, 2021 - 2033 (USD Million)
• Table 4 U.S. Minimally Invasive Surgery (MIS) market, by method, 2021 - 2033 (USD Million)
• Table 5 U.S. Minimally Invasive Surgery (MIS) market, by payer type, 2021 - 2033 (USD Million)
• Table 6 U.S. Minimally Invasive Surgery (MIS) market, by end-use, 2021 - 2033 (USD Million)

List of figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. Minimally Invasive Surgery (MIS): market outlook
• Fig. 9 U.S. Minimally Invasive Surgery (MIS) market competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. Minimally Invasive Surgery (MIS) market driver impact
• Fig. 15 U.S. Minimally Invasive Surgery (MIS) market restraint impact
• Fig. 16 U.S. Minimally Invasive Surgery (MIS) market strategic initiatives analysis
• Fig. 17 U.S. Minimally Invasive Surgery (MIS) market: surgical specialty movement analysis
• Fig. 18 U.S. Minimally Invasive Surgery (MIS) market: surgical specialty outlook and key takeaways
• Fig. 19 General surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Gastrointestinal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Gynecological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Urological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Cardiothoracic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Orthopedic & spine surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Neurosurgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Colorectal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Bariatric surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Vascular & endovascular surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Plastic & reconstructive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Minimally Invasive Surgery (MIS) market: method movement analysis
• Fig. 31 U.S. Minimally Invasive Surgery (MIS) market: method outlook and key takeaways
• Fig. 32 Laparoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Thoracoscopic surgery/VATS market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 Robotic-assisted surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Endoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Catheter-based interventional procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Minimally Invasive Surgery (MIS) market: payer type movement analysis
• Fig. 39 U.S. Minimally Invasive Surgery (MIS) market: payer type outlook and key takeaways
• Fig. 40 Private health insurance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Medicare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Medicaid market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Out-of-pocket/self-pay market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Other payers market revenue estimates and forecasts, 2021 - 2033 (USD Million) - 2033 (USD Million)
• Fig. 45 Minimally Invasive Surgery (MIS) market, end use outlook key takeaways (USD Million)
• Fig. 46 Minimally Invasive Surgery (MIS) market end use movement analysis 2024 & 2033 (USD Million)
• Fig. 47 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 51 Participant categorization- U.S. Minimally Invasive Surgery (MIS) market
• Fig. 52 Market share of key market players- U.S. Minimally Invasive Surgery (MIS) market